More and more biosimilars are entering the market across a wide variety of specialties. That’s why Spotlight on Biosimilars is here to break down everything you need to know about this novel class of drugs, like the benefits, challenges, and other key considerations.
APP Biosimilar Education Video Series Module 3
APP Biosimilar Education Video Series Module 4
Ross M. Maltz, MD
PeerHow Similar Are Biosimilar Insulins?
What Biotech Companies Want in Generic Legislation